• Publications
  • Influence
Preoperative localization and radioguided parathyroid surgery.
Clinical or subclinical hyperparathyroidism is one of the most common endocrine disorders. Excessive secretion of parathyroid hormone is most frequently caused by an adenoma of >or=1 parathyroidExpand
  • 217
  • 13
  • PDF
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
PURPOSE Radioembolization (RE) using (90)Y-microspheres is an effective and safe treatment for patients with unresectable liver malignancies. Radiation-induced liver disease (RILD) is rare after RE;Expand
  • 208
  • 7
Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations.
Therapy with 90Y-microspheres is emerging as a mainstream treatment modality in the management of patients with primary and metastatic liver cancer (1,2). The technique involves the administration ofExpand
  • 122
  • 7
  • PDF
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined
Summary Background Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liverExpand
  • 116
  • 4
  • PDF
The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy
PurposeFunctional tumor volume (FTV) and total lesion glycolysis (TLG) are measures of metabolic activity of tumors determined by fluorodeoxyglucose (FDG) positron emission tomography (PET)/CTExpand
  • 71
  • 4
Fractionated radioimmunotherapy with 90Y‐clivatuzumab tetraxetan and low‐dose gemcitabine is active in advanced pancreatic cancer
It has been demonstrated that the humanized clivatuzumab tetraxetan (hPAM4) antibody targets pancreatic ductal carcinoma selectively. After a trial of radioimmunotherapy that determined the maximumExpand
  • 67
  • 4
Posttherapy Radiation Safety Considerations in Radiomicrosphere Treatment with 90Y-Microspheres
Radiomicrosphere treatment involves the intrahepatic arterial administration of 90Y-resin or 90Y-glass microspheres. The microspheres are biocompatible, but not biodegradable, and little to no 90YExpand
  • 42
  • 4
  • PDF
Hepatic Structural Dosimetry in 90Y Microsphere Treatment: A Monte Carlo Modeling Approach Based on Lobular Microanatomy
Selective internal radiation treatment (SIRT) via intrahepatic arterial administration of 90Y microspheres is an effective therapeutic modality. The conventional and generally applied MIRD schema isExpand
  • 66
  • 4
Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio
BackgroundTreatment records and follow-up data on 40 patients with primary and metastatic liver malignancies who underwent a single whole-liver treatment with Y-90 resin microspheres (SIR-Spheres®Expand
  • 135
  • 3
The Role of Fluorine-18 Deoxyglucose Positron Emission Tomography in the Management of Patients With Metastatic Melanoma: Impact on Surgical Decision Making
Malignant melanoma can metastasize to almost any organ site. Optimal management requires sensitive radiographic evaluation of the entire body. The optimal management of patients with metastaticExpand
  • 121
  • 2